Sunny Pharmtech Inc.
Sunny Pharmtech Inc. engages in the research, development, and sale of new and generic drug in Taiwan, the United States, and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitami… Read more
Sunny Pharmtech Inc. (6676) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.107x
Based on the latest financial reports, Sunny Pharmtech Inc. (6676) has a cash flow conversion efficiency ratio of -0.107x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-96.00 Million) by net assets (NT$894.85 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sunny Pharmtech Inc. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Sunny Pharmtech Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sunny Pharmtech Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sunny Pharmtech Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Morn Sun Feed Mill Corp
TWO:1240
|
0.045x |
|
Hyundai Hcn
KO:126560
|
0.020x |
|
BYC Co Ltd
KO:001465
|
0.004x |
|
Eastern Michigan Financial Corporation
PINK:EFIN
|
N/A |
|
Patrangsit Healthcare Group Public Company Limited
BK:PHG
|
0.015x |
|
Bastei Lübbe AG
XETRA:BST
|
-0.015x |
|
Sierra Madre Gold and Silver Ltd
PINK:SMDRF
|
-0.004x |
|
Pullup Entertainment Société anonyme
PA:ALPUL
|
0.189x |
Annual Cash Flow Conversion Efficiency for Sunny Pharmtech Inc. (2019–2024)
The table below shows the annual cash flow conversion efficiency of Sunny Pharmtech Inc. from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.05 Billion | NT$-37.10 Million | -0.035x | -211.62% |
| 2023-12-31 | NT$1.20 Billion | NT$38.10 Million | 0.032x | +14.51% |
| 2022-12-31 | NT$969.30 Million | NT$26.88 Million | 0.028x | +190.93% |
| 2021-12-31 | NT$1.13 Billion | NT$-34.35 Million | -0.030x | -22.29% |
| 2020-12-31 | NT$1.04 Billion | NT$-26.04 Million | -0.025x | +75.75% |
| 2019-12-31 | NT$1.15 Billion | NT$-117.86 Million | -0.103x | -- |